Summary: ABC News explains how generic ketamine can be used off-label in the treatment of depression and other mental health conditions, making it “the only widely available psychedelic medication,” and examines the therapeutic potential of less accessible psychedelic-assisted treatment options that are not yet FDA-approved for any medical application.
“Psychedelics like MDMA and psilocybin may require a couple of more years until they receive FDA approval, according to Rick Doblin, Executive Director of the Multidisciplinary Association for Psychedelic Studies.” Until then, ketamine-assisted therapy “may be the closest legal equivalent,” says author Nicholas Nissen, M.D.
Originally appearing here.